Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant

Published:2022-02-14 Issue:3 Volume:42 Page:233-240
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Sivakumar Akhilesh¹^ORCID,Bryson Evan B.²,Hall Kevin H.¹,Maples Kathryn T.¹,Goyal Subir³,Joseph Nisha S.⁴,Hofmeister Craig C.⁴,Kaufman Jonathan L.⁴,Lonial Sagar⁴,Nooka Ajay K.⁴,Harvey Robert Donald⁴⁵

Affiliation:

1. Department of Pharmacy Winship Cancer Institute of Emory University Atlanta Georgia USA

2. Department of Pharmacy University of Kentucky Healthcare Lexington Kentucky USA

3. Department of Biostatistics Shared Resource Winship Cancer Institute of Emory University Atlanta Georgia USA

4. Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta Georgia USA

5. Department of Pharmacology and Chemical Biology Emory University School of Medicine Atlanta Georgia USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2667

Reference14 articles.

1. Cytotoxic alpha amino acids and peptides;Bergel F;Br Emp Cancer Campaign A,1953

2. Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation

3. L-Type Amino Acid Transporter-1 Overexpression and Melphalan Sensitivity in Barrett's Adenocarcinoma

4. Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods

5. LAT2, a New Basolateral 4F2hc/CD98-associated Amino Acid Transporter of Kidney and Intestine

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction;JCO Oncology Practice;2023-09